GluR
GluR (glutamate receptor) is a group of synaptic receptors located primarily on the membranes of neuronal cells.
Products Related to GluR(118)
- GC12899CBiPES hydrochlorideCAS: 856702-40-4Purity: >98%
positive allosteric modulator of the mGlu2 receptor
- GC12985(RS)-3-HydroxyphenylglycineCAS: 31932-87-3Purity: >98%
PI-linked metabotropic glutamate receptors agonist
- GC13222N-Acetylglycyl-D-glutamic acidCAS: 135701-69-8Purity: >98%
Excitatory peptide that induces seizures
- GC13288(RS)-4-Carboxy-3-hydroxyphenylglycineCAS: 134052-66-7Purity: >98%
broad spectrum EAA agonist/antagonist
- GC14003VU 0155041 sodium saltCAS: 1259372-69-4Purity: >98%
VU 0155041 sodium salt is a potent, selective positive allosteric modulator (PAM) of mGluR4, with EC50s of 798 nM and 693 nM for human and rat mGluR4, respectively.
- GC14097LY 487379 hydrochlorideCAS: 353229-59-1Purity: >98%
Positive allosteric modulator of mGlu2 receptors
- GC14124(R)-3-Carboxy-4-hydroxyphenylglycineCAS: 13861-03-5Purity: >98%
NMDA and AMPA/kainate receptor antagonist
- GC14172Ro 67-4853CAS: 302841-89-0Purity: >98%
Positive allosteric modulator of mGlu group I receptors
- GC14176(S)-4-CarboxyphenylglycineCAS: 134052-73-6Purity: >98%
group I metabotropic glutamate receptor antagonist
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC12485 | Ro 67-7476 | 298690-60-5 | >99.50% | |
positive allosteric modulator of mGlu1 receptors | ||||
| GC12510 | BINA | 866823-73-6 | >99.00% | |
BINA (BINA) is a selective human mGluR2 (hmGluR2) potentiator for the treatment of many neurological disorders. | ||||
| GC12532 | CHPG | 170846-74-9 | >98.00% | |
CHPG is a selective metabotropic glutamate receptor 5 (mGlu5) agonist. | ||||
| GC12699 | (±)-LY 395756 | 852679-66-4 | >98% | |
ligand for mGlu2 and mGlu3 receptor | ||||
| GC12705 | Cinnabarinic acid | 606-59-7 | >98.00% | |
A mGlu4 receptor agonist | ||||
| GC12831 | LY 367385 | 198419-91-9 | >99.00% | |
mGlu1a receptor antagonist | ||||
| GC12899 | CBiPES hydrochloride | 856702-40-4 | >98% | |
positive allosteric modulator of the mGlu2 receptor | ||||
| GC12960 | DL-AP4 Sodium salt | 1263093-79-3 | >98% | |
Broad spectrum EAA ligand | ||||
| GC12985 | (RS)-3-Hydroxyphenylglycine | 31932-87-3 | >98% | |
PI-linked metabotropic glutamate receptors agonist | ||||
| GC13046 | UBP1112 | 339526-74-8 | >98% | |
group III mGlu receptor antagonist | ||||
| GC13120 | Desmethyl-YM 298198 | 1177767-57-5 | >98% | |
mGlu1-selective antagonist | ||||
| GC13126 | DMeOB | 40252-74-2 | >98% | |
Negative allosteric modulator of mGlu5 | ||||
| GC13192 | E4CPG | 170846-89-6 | >98.00% | |
group I/group II metabotropic glutamate receptor antagonist | ||||
| GC13222 | N-Acetylglycyl-D-glutamic acid | 135701-69-8 | >98% | |
Excitatory peptide that induces seizures | ||||
| GC13288 | (RS)-4-Carboxy-3-hydroxyphenylglycine | 134052-66-7 | >98% | |
broad spectrum EAA agonist/antagonist | ||||
| GC13548 | MSPG | 169209-64-7 | >98% | |
mGlu receptor antagonist | ||||
| GC13773 | (RS)-4-Carboxyphenylglycine | 7292-81-1 | >98% | |
broad spectrum EAA ligand | ||||
| GC13881 | L-CCG-l | 117857-93-9 | >98% | |
group II metabotropic glutamate receptor agonist | ||||
| GC14003 | VU 0155041 sodium salt | 1259372-69-4 | >98% | |
VU 0155041 sodium salt is a potent, selective positive allosteric modulator (PAM) of mGluR4, with EC50s of 798 nM and 693 nM for human and rat mGluR4, respectively. | ||||
| GC14097 | LY 487379 hydrochloride | 353229-59-1 | >98% | |
Positive allosteric modulator of mGlu2 receptors | ||||
| GC14124 | (R)-3-Carboxy-4-hydroxyphenylglycine | 13861-03-5 | >98% | |
NMDA and AMPA/kainate receptor antagonist | ||||
| GC14146 | AIDA | 168560-79-0 | >98% | |
AIDA (AIDA), a rigid (carboxyphenyl) glycine derivative, is a relatively potent and selective antagonist of group I metabotropic glutamate receptors (mGlu1a) with an IC50 of 214 μM. | ||||
| GC14172 | Ro 67-4853 | 302841-89-0 | >98% | |
Positive allosteric modulator of mGlu group I receptors | ||||
| GC14176 | (S)-4-Carboxyphenylglycine | 134052-73-6 | >98% | |
group I metabotropic glutamate receptor antagonist | ||||